IL17A and glaucoma: In conclusion, reduction in IL-6 would help in reducing the effects of glaucoma as with the other inflammatory cytokines of CXCR4, IL-17, IL-1β, and TNF-α which are known to be increased in PC-12-glaucoma model cells without betalain treatment.